The staff of the Site took an active part in the 16th National Congress of Therapists. The Congress program covered the widest possible range of issues of diagnosis, prevention and treatment of internal diseases. We thank the organizers for the invitation!

We continue to participate in protocols for the treatment of inflammatory bowel diseases: a portfolio of new studies on Crohn's disease and ulcerative colitis.

Participation in a clinical study of a new biological therapy for the treatment of Covid-19 infection in children is proposed.

Our partners

Protagonist
Gilead
Mithra
PRA Health Sciences
Pfizer
Rusmo-AG
Sanofi
Abbvie
Icon
Astra Zeneca
Gedeon Richter
Cromos Pharma
PPD
X7 Research
Synteract
IQVIA
Biorasi | Built for Faster Clinical Trials
PSI
ALK
Galecto
SRG
Clinipas
Astellas
Janssen
JonsonAndJonson
OCT
Celgen
Bristol-Myers Squibb Company
Biogen